Gastro-Intestinal DisorderNCT07565454
Evaluation of Hepato-Pancreato-Biliary
An observational study of Gastro-Intestinal Disorder, run by Methodist Health System at 1 site in United States.
Trial summary
Some reports cite over 80% of surgery residency graduates are seeking additional training to improve on their experiences to be ready for practice. The Fellowship Council created several fellowship tracts including HPB (Hepato-Pancreato-Biliary),Advanced GI (gastrointestinal) and Minimally Invasive surgery to address… Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Gastro-Intestinal Disorder
- What is being tested?
- Evaluate and compare the efficacy of our training within the Fellowship Council curriculums
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 100 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Apr 2021to Jan 2028
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: This study will follow a general survey design intended to create various surveys to help improve fellowship curriculum to better serve future HPB and Advance GI Surgeons.
Who may be able to join
- Current, and past fellows of Fellowship Council(FC )sponsored fellowship including Americas Hepato-Pancreato-Biliary Association(AHPBA)-accredited HPB and Advanced GI surgery fellowship.
- Current senior surgeons involved in Fellowship Council(FC) fellowship training.
Who cannot join
- Fellows who choose not to respond to the survey
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Methodist Dallas Medical Center- Clinical Research Institute
Dallas, Texas, 75203
Colette Ngo Ndjom, 214-947-1289, ClinicalResearch@mhd.com
Kavya Mankulangara, 214-947-4604, ClinicalResearch@mhd.com
About this study
Official title: Evaluation of HPB or Advanced GI Surgery Fellowship Training
Some reports cite over 80% of surgery residency graduates are seeking additional training to improve on their experiences to be ready for practice. The Fellowship Council created several fellowship tracts including HPB (Hepato-Pancreato-Biliary),Advanced GI (gastrointestinal) and Minimally Invasive surgery to address this issue, and bridge the gap in training between residency and real life practice in those that seek a practice in HPB or complex GI surgery, respectively. By the end of fellowship, the core goal is to make the graduating fellows ready for independent practice in HPB or complex GI surgery cases.
Read the detailed description
The main aim of this study is to evaluate and compare the efficacy of our training within the Fellowship Council curriculums. In addition, we aim to examine the job market and perceptions regarding training for graduates of the Fellowship Council's fellowships domains.
- Conditions
- Gastro-Intestinal Disorder
- Being tested
- Evaluate and compare the efficacy of our training within the Fellowship Council curriculums
- Medical subject headings
- Digestive System Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Evaluate and compare the efficacy of our training within the Fellowship Council curriculumsBehavioural
The product of our fellowship must be constantly evaluated to make sure the goal, which is to produce competent, independent surgeons capable of treating Hepato-Pancreato-Biliary(HPB) and complex Gastrointestinal(GI) surgery disease processes is met.
| Study group | Role | What they receive |
|---|---|---|
| Present general surgery residents | compare current fellowship structure to better serve future surgeons. Receives: Behavioral: Evaluate and compare the efficacy of our training within the Fellowship Council curriculums |
What is being measured
The primary outcome is the main question the study is designed to answer.
Efficacy of HPB and Advanced GI surgery fellowship curriculums
Survey questions will either examine the readiness of our trainees coming into the fellowship, our current fellowship curriculum, and/or the outcome of our fellows once they complete and graduate from their advanced training.
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 May 2026
- Study start1 Apr 2021
- Primary completionJan 2027 (estimated)
- Study completionJan 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Gastro-Intestinal DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Retrospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Methodist Health System
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Rohan Jeyarajah, MD, Principal investigator, Methodist Health System
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07565454
- Sponsor's protocol ID
- 038.HPB.2018.R
- Status last verified
- Jan 2026
- First submitted
- 18 Mar 2026
- Last updated
- 10 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: All information will be blinded in compliance with good clinical practice. The investigator will make all possible efforts to ensure compliance with all policies regarding sharing of Survey or research information. Only de-identified surveyor information will be shared in relevant research mediums. These mediums may range from national, regional, local and/or international sites. In addition, study data and findings may be submitted for presentation at local and national conferences. As study protocol is intended to cover multiple surveys we are unaware where these publications will be used at this time. Publication reference will be added ad hoc to maintain in records.
Study at a glance
From the registry record, last updated by the sponsor on 10 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of HPB or Advanced GI Surgery Fellowship Training
- ClinicalTrials.gov ID
- NCT07565454
- Acronym / sponsor ID
- 038.HPB.2018.R
- Conditions
- Gastro-Intestinal Disorder
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Methodist Health SystemUniversity, hospital or other
- Study start
- 1 Apr 2021 (actual)
- Primary completion
- Jan 2027 (estimated)
- Study completion
- Jan 2028 (estimated)
- First posted
- 4 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Some reports cite over 80% of surgery residency graduates are seeking additional training to improve on their experiences to be ready for practice. The Fellowship Council created several fellowship tracts including HPB (Hepato-Pancreato-Biliary),Advanced GI (gastrointestinal) and Minimally Invasive surgery to address this issue, and bridge the gap in training between residency and real life practice in those that seek a practice in HPB or complex GI surgery, respectively. By the end of fellowship, the core goal is to make the graduating fellows ready for independent practice in HPB or complex GI surgery cases.
Detailed description
The main aim of this study is to evaluate and compare the efficacy of our training within the Fellowship Council curriculums. In addition, we aim to examine the job market and perceptions regarding training for graduates of the Fellowship Council's fellowships domains.
Study design
- Observational model
- Other
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Present general surgery residents | – | Behavioral: Evaluate and compare the efficacy of our training within the Fellowship Council curriculumscompare current fellowship structure to better serve future surgeons. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- This study will follow a general survey design intended to create various surveys to help improve fellowship curriculum to better serve future HPB and Advance GI Surgeons.
Key inclusion criteria (2 listed)
- Current, and past fellows of Fellowship Council(FC )sponsored fellowship including Americas Hepato-Pancreato-Biliary Association(AHPBA)-accredited HPB and Advanced GI surgery fellowship.
- Current senior surgeons involved in Fellowship Council(FC) fellowship training.
Key exclusion criteria (1 listed)
- Fellows who choose not to respond to the survey
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Evaluate and compare the efficacy of our training within the Fellowship Council curriculumsThe product of our fellowship must be constantly evaluated to make sure the goal, which is to produce competent, independent surgeons capable of treating Hepato-Pancreato-Biliary(HPB) and complex Gastrointestinal(GI) surgery disease processes is met. | Behavioural | Present general surgery residents |
Primary outcome
Efficacy of HPB and Advanced GI surgery fellowship curriculums
Time frame: 1 year
Survey questions will either examine the readiness of our trainees coming into the fellowship, our current fellowship curriculum, and/or the outcome of our fellows once they complete and graduate from their advanced training.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Jun 2026.
- Individual participant dataSharing planned: Yes. All information will be blinded in compliance with good clinical practice. The investigator will make all possible efforts to ensure compliance with all policies regarding sharing of Survey or research information. Only de-identified surveyor information will be shared in relevant research mediums. These mediums may range from national, regional, local and/or international sites. In addition, study data and findings may be submitted for presentation at local and national conferences. As study protocol is intended to cover multiple surveys we are unaware where these publications will be used at this time. Publication reference will be added ad hoc to maintain in records.
Related trials for Gastro-Intestinal Disorder
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingPhase 2/3
Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types
Oesophageal Cancer, Gastric Cancer
Not yet recruitingPhase 1
An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 Substrates
Ulcerative Colitis, Crohn's Disease
Recruiting
Safety and Performance of UCon Patch Electrode
Urinary Incontinence, Urinary Incontinence, Urge
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Rohan Jeyarajah, MD principal investigator
Methodist Health System
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Gastro-Intestinal Disorder, run by Methodist Health System at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 10 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Crystee Cooper, DHEd (214-947-1280, ClinicalResearch@mhd.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Efficacy of HPB and Advanced GI surgery fellowship curriculums (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2026.